Events and Presentations
Presentations and Posters
| Date | Title | Format |
|---|---|---|
|
Jan 14, 2021
|
Current Corporate Presentation
|
Current Corporate Presentation 983.2 KB
|
|
Dec 09, 2020
|
SABCS: A Phase 2 study of poziotinib in patients with HER2-positive metastatic breast cancer heavily pre-treated with HER2-targeted therapy
|
|
|
Dec 09, 2020
|
SABCS: Open-label, phase 1 study to evaluate duration of severe neutropenia after same-day dosing of eflapegrastim in patients with breast cancer receiving docetaxel and cyclophosphamide
|
|
|
Dec 09, 2020
|
SABCS: Pooled efficacy analysis from two phase 3 studies in patients receiving eflapegrastim, a novel, long-acting granulocyte-colony stimulating factor, following TC for early-stage breast cancer
|
Upcoming Event
More events are coming soon.
Archived Events
| Date | Title |
|---|---|
|
Jan 21, 2021
1:00 PM EST
|
|
|
Jan 14, 2021
1:45 PM EST
|
|
|
Jan 11, 2021
6:00 AM EST
|
|
|
Dec 22, 2020
1:30 PM PST
|
View Presentation 478.3 KB
|
|
Nov 18, 2020
2:20 PM EST
|
|
|
Nov 16, 2020
2:40 PM EST
|
|
|
Nov 4, 2020
1:30 PM PST
|
|
|
Sep 18, 2020
12:00 AM EDT
|
View Presentation 100.5 KB
|
|
Sep 17, 2020
10:40 AM EDT
|
|
|
Sep 14, 2020
2:00 PM EDT
|
|
|
Aug 10, 2020
1:30 PM PDT
|
|
|
Jul 27, 2020
1:30 PM PDT
|
|
|
Jun 22, 2020
9:00 AM EDT
|
View Poster 2.4 MB
|
|
Jun 3, 2020
9:00 AM EDT
|
|
|
May 7, 2020
1:30 PM PDT
|
|
|
Apr 28, 2020
8:30 AM EDT
|
View Presentation 251.2 KB
|
|
Apr 27, 2020
2:05 PM EDT
|
View Presentation 347.2 KB
|
|
Mar 10, 2020
4:50 PM EDT
|
|
|
Feb 27, 2020
1:30 PM PST
|
|
|
Feb 13, 2020
4:00 PM EST
|